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Edited by Takashi GojoboriAbstract Protein sumoylation is an important reversible post-
translational modiﬁcation of proteins in the nucleus, and it
orchestrates a variety of the cellular processes. Genome-wide
analysis of functional abundance and distribution of Small Ubiq-
uitin-related MOdiﬁer (SUMO) substrates may shed a light on
how sumoylation is involved in nuclear biological processes and
functions. Two interesting questions about sumoylation have
emerged: (1) how many SUMO substrates exist in mammalian
proteomes, such as human and mouse, (2) and what are their
functions and how are they involved in a variety of biological pro-
cesses? To address these two questions,we present an in silico
genome-scale analysis for SUMO substrates in human. Based
on the pattern recognition and phylogenetic conservation, we re-
trieved a list of 2683 potential SUMO substrates conserved in
both human and mouse. Then, by functional enrichment analysis,
we surveyed the over-represented GO terms and functional do-
mains of them against the whole human proteome. Besides the
consistence between our analyses and in vivo or in vitro work,
the in silico predicted candidates also point to several potential
roles of sumoylation, e.g., perception of sound. These potential
SUMO substrates in human are of great value for further in vivo
or in vitro experimental analysis.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Small Ubiquitin-related MOdiﬁer (SUMO) proteins are
ubiquitously expressed in eukaryotic cells [1–4]. They are
reversiblylinked to speciﬁc lysine residues of numerous sub-
strates by sumoylation, and are implicated in various intracel-
lular processes, such as nucleocytoplasmic signal transduction
[5], transcription [6–8], stress response [9] and mitosis/cell-cycle
progression [10,11], etc. SUMO proteins belong to the super-*Corresponding author. Fax: +86 551 3607141.
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doi:10.1016/j.febslet.2005.04.076family of ubiquitin-like modiﬁers (UBLs) [12], and consist of
three components in mammalian cells: SUMO-1, SUMO-2,
and SUMO-3 [13]. Only recently was another component
SUMO-4 discovered in human [14]. SUMO proteins are highly
conserved from yeast to human.
Conventional experimental approaches are employed to
identify SUMO substrates with their sites in vivo or in vitro,
although labor-intensive and time-consuming. Before millen-
nium, there were only 12 experimentally veriﬁed SUMO sub-
strates [4]. Recently, several genomic/proteomic-wide
analyses of SUMO substrates have been deployed by mass
spectrometry (MS) approaches in budding yeast [15–20].
Approximately, 500 potential SUMO substrates in these
large-scale experiments were found. These results are excel-
lent candidates for further experimental consideration.
Moreover, it is of great interest to identify novel SUMO
substrates in mammals, especially in human given the recent
completion of human genome project [21–25]. Due to the
complexity of human proteome, only about two hundred
candidates were found so far, and the exact sumoylation
sites on most of these substrates remain elusive. In order
to provide a more comprehensive view on sumoylation in
human and on how they are involved in all kinds of intra-
cellular biochemical processes, we developed a program SSP
(SUMO substrates prediction) and conducted an in silico
genome-wide analysis for nuclear SUMO substrates in hu-
man, based on pattern recognition and phylogenetic conser-
vation approaches.
The majority of the SUMO substrates have a consensus
motif with four amino acids. There are several motifs re-
ported in the literatures: such as w-K-X-E (w is a hydropho-
bic amino acid) [2,4,23] and [VILMAFP]K.E (http://
www.elm.eu.org/elmPages/MOD_SUMO.html) [26], etc. And
a nuclear localization signal (NLS) suﬃces for SUMO conju-
gation in vivo [27], with only a few exceptions [28]. So we fol-
low the w-K-X-E motif with a NLS as the consensus pattern
for SUMO substrates prediction. In addition, the potential
false positive hits are greatly reduced by phylogenetic conser-
vation. For the prediction of sumoylation sites, SSP is nearly
as sensitive as the existing tool SUMOplot (http://www.
abgent.com/doc/sumoplot), with signiﬁcantly improved speci-
ﬁcity (see in Table 2).
We have generated a list of 2683 potential SUMO
substrates conserved between human and mouse. We
adopted the functional enrichment analysis to search forblished by Elsevier B.V. All rights reserved.
Table 1
The prediction results of known SUMO substrates
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Table 1 (continued)
85 experiment-veriﬁed SUMO substrates are listed. Our method can predict 64 of them correctly (75%).
A. Fernandez-Lloris R. et al. (2002) Post-translational Sox6 protein modiﬁcation by SUMO-1. In: 28th Meeting of the Federation of European
Biochemical Societies, Istanbul, Turkey, pp. 20–25.
aNo consensus motif (6 proteins).
bNot ‘‘nuc’’ (nuclear) hit by PSORT II prediction (9 proteins).
cExcluded by orthlogy information (6 proteins).
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(Interpro) of the potential SUMO substrates against the
whole human proteome. Our analyses of these potential sub-
strates support the previous prediction of the functional rele-
vance of sumoylation. For example, transcription factors and
protein kinases are abundant in SUMO substrates, playing
important roles in transcriptional regulation and gene expres-
sion [6–8] and signal transduction [1,2,29]. However, surpris-
ingly, newly identiﬁed sumoylation candidates also point to
several potential roles of sumoylation, e.g., perception of
sound. Further analyses of these candidates in vivo or in vi-
tro will provide insights into the function of sumoylation in
mammalians, especially human.2. Materials and methods
2.1. Identiﬁcation of SUMO substrates with their sites in human and
mouse
We took the orthology-relationship data of mouse and human with
the corresponding sequences from the InParanoid database (Version
2.6, 30/03/2004) [30]. For the 34499 mouse sequences and 36379 hu-
man sequences in InParanoid, we ﬁrstly scanned the sequences for
the consensus motif w-K-X-E in mouse and human, respectively.
Sequences without such motif were excluded. Then we got 13026
sequences in mouse and human, respectively. By PSORT II [31], we
predicted the sub-cellular localization of the retained sequences.
Only proteins with predicted nuclear localization were retained. After
this step, there were 6662 sequences in mouse and 7649 in human,
respectively.
In order to eliminate the potential false positive results, we followed
a simple rule below: for the pairwise orthologs between the retained
mouse and human proteins, there must be at least one consensus
SUMO substrate motif at the same position after sequence alignment.
Thus, proteins without such orthologs were excluded. After the se-
quence alignment, orthologs sharing no consensus motif at the same
position were also excluded, resulting a ﬁnal 2683 orthologous proteins
in both mouse and human proteomes.2.2. Statistical analysis for SUMO substrates
We downloaded the GO (08/10/2004) and Interpro (23/06/2004) [32]
association ﬁles from EBI (ftp://ftp.ebi.ac.uk/pub/) and searched for
the GO and Interpro annotations of human proteins. Among 36379
human proteins of InParanoid, there are 24090 and 26873 annotated
with at least one GO and Interpro term, respectively, and there are
1956 and 2264 proteins of our 2683 potential SUMO substrates anno-
tated, separately. Following a statistical approach described before
[33], we compared the group S (predicted SUMO substrates of human)
against the group W (whole human proteome) to ﬁnd a GO/Interpro
term t that occurred more frequently in group S than in group W. Here
we deﬁne:N total number of proteins in group W annotated by GO/
Interpron number of proteins in group W annotated by GO/Interpro
term tM total number of proteins in group S annotated by GO/Inter-
prom number of proteins in group S annotated by GO/Interpro
term tThen we calculate the enrichment ratio of GO/Interpro term t in group
S, and with the equation of the hypergeometric distribution, we can
also calculate its P-value:
Enrichment ratio ¼
m
M
n
N
;
p-value ¼
Xn
m0¼m
M
m0
 
NM
nm0
 
N
n
  ðEnrichment ratioP 1Þ
or
p-value ¼
Xm
m0¼0
M
m0
 
NM
nm0
 
N
n
  ðEnrichment ratio < 1Þ.
In this work, we only consider the over-representation of GO/Interpro
groups with Enrichment_ratio P 1.
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3.1. Accuracy of SSP1.0 program
It is reported that evolutionary stable sites can be used to im-
prove the prediction speciﬁcity for functional sites/motifs [34],
based on the hypothesis that functional sites/motifs should be
more conserved than random pseudo-sites/motifs. For our
phylogenetic conservation analysis, we chose distance near
specie mouse for human rather than other too distant species
such as budding yeast or ﬂy, to avoid missing too many real
sumoylation sites. Too near species such as primates are not
used, because these proteomes are too similar with human
and cannot reduce the potential false positives much. So weTable 2
The comparison of the sumoylation site prediction against SUMOplot
Protein name Sumoylation sites
Veriﬁed
AP-2a K10
AP-2b K10
AP-2c K10
AR (androgen receptor) K386, K520
ARNT (aryl hydrocarbon receptor nuclear transporter) K245
C/EBPb-1 K173
C/EBPa (CCAAT/enhancer-binding protein alpha) K159
c-Jun K229
c-Myb K503, K527
Elk-1 K230, K249
FAK (focal adhesion kinase) K152
GR (glucocorticoid receptor) K277, K293
GRIP1 K239, K731, K78
HIPK2 K1182
hnRNP C K237
HSF1 (heat shock transcription factor 1) K298
HSF2 (heat shock transcription factor 2) K82
IjBa K21
LEF1 K27, K269
NEMO/IKKc K277, K309
Nurr1 (NR4A2, RNR-1,TINUR, HZF-3) K91, K577
p300/CBP K1017, K1029
p73a K627
PML (promyelocytic leukaemia protein) K65, K160, K490
PR (progesterone receptor) K388
SALL1 K1086
Smad4 K113, K159
Sp3 K539
SREBP-1a K123, K418
SRF (serum response factor) K147
Steroid receptor coactivator SRC-1/ NCoA-1 K732, K774
Tcf-4 K297
TDG K330
TEL K99
TIF1a K690, K708
TOPO I K117, K153
Topors K560
GATA4 K366
ZNF67 K411
PLAG1 K244, K263
Steroidogenic factor 1 K199, K194
GATA1 K137
NFAT K684, K897
Total sites 63
63 veriﬁed sumoylation sites of 43 known SUMO substrates are chosen.
aSSP 1.0 hits are in bold character font.
bSUMOplot hits (motifs with high probability)/total predicted sites (motifs w
cSUMOplot hits (all)/total predicted sites (all).
dSSP 1.0 hits/total predicted sites.adopted the phylogenetic conservation between human and
mouse to reduce the potential false positives. Curated from
the published work, we got 85 experimental veriﬁed SUMO
substrates (see Table 1). The SSP 1.0 can predict 64 (75%) of
them correctly.
For precise sumoylation site prediction, we compare our
computational results with the existing tool SUMOplot (see
Table 2). For the 63 known sumoylation sites, our method
could recover 51 of them with sensitivity Sn  81%, which is
similar to the SUMOplot results 81% (motifs with high prob-
ability) or 84% (all). Yet the speciﬁcity Sp of our approach is
signiﬁcantly improved to 60% (51 in a total of 86), compared
to SUMOplot 31% (motifs with high probability) or 15%SSP 1.0 SUMOplot
IKYEa 1/1b; (1/4)c
IKYE 1/1; (1/5)
IKYE 1/1; (1/4)
IKLE, VKSE 2/3; (2/6)
VKKE 0/2; (0/5)
LKAE 1/2; (1/4)
LKAE 1/1; (1/1)
AKME, LKEE, IKAE 1/3; (1/4)
IKQE, IKQE 2/5; (2/10)
VKVE 2/2; (2/4)
WKYE 1/5; (1/17)
VKTE, IKQE, VKRE 0/1; (0/5)
8 VKLE, MKQE 2/7; (2/17)
LKIE, LKPE 0/3; (0/7)
IKKE,VKME 0/4; (1/12)
VKPE, LKSE, MKHE, VKEE 1/6; (1/9)
VKQE, IKQE, LKSE 1/6; (1/9)
LKKE, MKDE 1/4; (1/4)
FKDE, VKQE 2/3; (2/7)
AKQE, LKEE 1/8; (1/13)
IKVE, LKLE 2/4; (2/10)
MKTE, VKEE, VKVE, VKEE, FKPE 2/11; (2/22)
IKEE 1/3; (1/7)
LKHE, IKME 3/6; (3/7)
IKEE 1/3; (1/6)
IKTE, IKTE 1/7; (1/15)
VKDE 1/3; (1/7)
IKDE, IKEE 1/3; (1/5)
IKEE, LKQE, VKTE 2/7; (2/11)
IKME 1/1; (1/3)
AKAE, IKLE, VKVE, IKLE, IKSE 1/7; (1/13)
FKDE, VKQE 1/6; (1/10)
VKEE 0/0; (0/8)
IKQE 0/2; (0/3)
IKQE, VKQE, IKLE 2/5; (2/11)
IKKE, IKTE, IKEE, FKIE, IKGE, MKLE 2/12; (2/29)
LKRE 0/4; (1/10)
IKTE 1/1; (1/2)
VKGE, VKEE 1/2; (1/5)
FKCE,VKTE, IKDE, LKGE 2/5; (2/11)
FKLE, IKSE 2/2; (2;3)
LKTE 1/1; (1/4)
IKTE, IKQE 2/3; (2/6)
51/86d 51/166; (53/355)
ith high probability).
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false positives while still keeps a satisfying sensitivity.
3.2. Functional abundance and distribution of SUMO substrates
SUMO substrates are implicated in many intracellular pro-
cesses. However, the systems biology of sumoylation remains
unclear. Thus, it is of great interest to illustrate in which func-
tions the nuclear SUMO substrates of human are signiﬁcantly
abundant. Here we perform a statistical analysis to predict
such signiﬁcance. Our analytical outcomes (see Table 3)
are consistent with several widely held, but yet to be systemat-
ically examined assumptions on the sumoylation involved
processes.
For example, sumoylation was proposed to play a role in
transcriptional regulation and gene expression [6–8], where
many SUMO substrates are transcription factors [1,2]. Are
there any strong correlations between transcriptional regula-
tion and sumoylation? From our analysis, we found that the
transcription factor and transcriptional regulation are both
among the top of the list of signiﬁcantly enriched functions
or processes (Table 3). In the human proteome, 2255,
and 1102 proteins are annotated with functions of DNA
binding (GO:0003677) and transcription factor activity
(GO:0003700), respectively. And there are also 2174 proteins
annotated with process of regulation of transcription, DNA-Table 3
The top 15 most enriched processes and functions in SUMO substrates
Description of GO term Number
annotated
The top 15 most enriched processes in SUMO substrates
Regulation of transcription, DNA-dependent (GO:0006355) 26.1% (51
Transcription from Pol II promoter (GO:0006366) 3.5% (69
Development (GO:0007275) 5.8% (11
Signal transduction (GO:0007165) 9.1% (17
Regulation of transcription from Pol II promoter (GO:0006357) 2.7% (52
Protein amino acid phosphorylation (GO:0006468) 6.7% (13
Cell growth and/or maintenance (GO:0008151) 3.4% (67
Cell cycle (GO:0007049) 2.5% (49
Intracellular signaling cascade (GO:0007242) 4.6% (90
Endocytosis (GO:0006897) 1.4% (27
Mitosis (GO:0007067) 1.3% (26
Perception of sound (GO:0007605) 1.2% (23
Morphogenesis (GO:0009653) 1.2% (23
Frizzled signaling pathway (GO:0007222) 0.5% (10
Negative regulation of transcription from Pol II promoter
(GO:0000122)
0.9% (18
The top 15 most enriched functions in SUMO substrates
DNA binding (GO:0003677) 27.1% (53
Transcription factor activity (GO:0003700) 15.5% (30
Nucleic acid binding (GO:0003676) 14.2% (27
Zinc ion binding (GO:0008270) 14.6% (28
Protein serine/threonine kinase activity (GO:0004674) 6.1% (11
Actin binding (GO:0003779) 3.7% (72
ATP binding (GO:0005524) 13.3% (26
Protein kinase activity (GO:0004672) 6.5% (12
RNA polymerase II transcription factor activity (GO:0003702) 2.1% (41
Steroid hormone receptor activity (GO:0003707) 1.5% (29
GTPase activator activity (GO:0005096) 1.8% (35
Transcription coactivator activity (GO:0003713) 2.2% (43
Ligand-dependent nuclear receptor activity (GO:0004879) 1.5% (29
Protein binding (GO:0005515) 11.9% (23
Calmodulin binding (GO:0005516) 1.8% (35
We list the top 15 of the over-represented functions and processes for furthe
aGroup S, the SUMO substrates.
bGroup W, whole human proteome.dependent (GO:0006355). In our data set, there are 530, 304,
and 510 proteins with the above three annotations, respec-
tively. So it could be estimated that about 1/4–1/3 of the tran-
scription factors are downregulated by sumoylation.
Interestingly, we found that the processes of transcription from
Pol II promoter (GO:0006366) and regulation of transcription
from Pol II promoter (GO:0006357) are highly correlated with
SUMO substrates. This supports the hypothesis that sumoyla-
tion may play a role at the promoter by modifying transcrip-
tion factors as chromatin-bound complexes, but not by
regulating transcription directly [1,2], and the functions of
transcription coactivator activity (GO:0003713) (see Table 3)
and transcription corepressor activity (GO:0003714)
(P < 107) are also signiﬁcantly represented. This ﬁnding is
consistent with the recent observations that sumoylation can
repress or activate transcription [1,2].
Several SUMO substrates were summarized to be essential
in signal transduction [1,2,29]. In Drosophila brain, the func-
tional dynamics of neuronal calcium/calmodulin-dependent
protein kinase II was regulated by sumoylation, which is
important for the diﬀerentiated nervous system [35]. In NF-jB
signaling pathways, the regulatory subunit of the IjB kinase
(IKK) complex NEMO/IKKc will be sumoylated to release
NF-jB from its inhibitor IjBa, inducing a survival response
against genotoxic stress [5,9]. In our data set, the processesof proteins
in group Sa
Number of proteins
annotated in group Wb
Enrichment
ratio
P-value
0) 9.0% (2174) 2.89 6.12E121
) 0.8% (204) 4.17 1.00E25
4) 2.6% (631) 2.23 2.96E16
8) 5.0% (1207) 1.82 2.06E15
) 0.8% (192) 3.34 4.13E15
1) 3.5% (850) 1.90 5.45E13
) 1.4% (341) 2.42 9.45E12
) 1.0% (240) 2.51 1.49E09
) 2.5% (609) 1.82 2.00E08
) 0.4% (108) 3.08 9.71E08
) 0.4% (103) 3.11 1.35E07
) 0.4% (87) 3.26 2.87E07
) 0.4% (107) 2.65 1.31E05
) 0.1% (26) 4.74 1.92E05
) 0.3% (74) 3.00 1.93E05
0) 9.4% (2255) 2.89 1.00E126
4) 4.6% (1102) 3.40 3.64E87
7) 7.6% (1823) 1.87 7.89E26
5) 8.2% (1968) 1.78 2.80E23
9) 2.3% (559) 2.62 7.18E23
) 1.1% (259) 3.42 4.25E21
0) 8.0% (1925) 1.66 3.69E17
8) 3.2% (776) 2.03 6.38E15
) 0.6% (138) 3.66 1.12E13
) 0.3% (75) 4.76 2.47E13
) 0.5% (110) 3.92 7.49E13
) 0.7% (158) 3.35 8.04E13
) 0.3% (79) 4.52 1.17E12
3) 8.0% (1907) 1.50 7.58E11
) 0.5% (132) 3.27 2.31E10
r discussion.
Table 4
The top 10 most over-represented protein domains in SUMO substrates
Description of Interpro term Number of proteins
annotated in group Sa
Number of proteins
annotated in group Wb
Enrichment
ratio
P-value
Serine/threonine protein kinase, active site (IPR008271) 5.1% (115) 1.8% (486) 2.81 8.69E25
Pleckstrin-homology-related (IPR011036) 5.0% (113) 2.0% (538) 2.49 5.71E20
Pleckstrin-like (IPR001849) 4.2% (94) 1.6% (421) 2.65 1.16E18
Serine/threonine protein kinase (IPR002290) 3.4% (78) 1.2% (328) 2.82 2.34E17
Zn-ﬁnger, C2H2 type (IPR007087) 8.2% (185) 4.4% (1177) 1.87 4.24E17
Zn-ﬁnger-like, PHD ﬁnger (IPR001965) 2.0% (46) 0.5% (139) 3.93 1.46E16
Homeodomain-like (IPR009057) 3.6% (81) 1.3% (362) 2.66 2.53E16
Protein kinase (IPR000719) 5.8% (132) 3.0% (796) 1.97 2.96E14
Protein kinase-like (IPR011009) 5.8% (131) 2.9% (790) 1.97 3.73E14
Winged helix DNA-binding (IPR009058) 2.6% (59) 0.9% (244) 2.87 8.25E14
We list the top 10 of the over-represented protein domains for further discussion.
aGroup S, the SUMO substrates.
bGroup W, whole human proteome.
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ing cascade (GO:0007242) are much enriched (P < 107),
which implies that sumoylation may be involved in signal
transduction extensively. We also ﬁnd that the GO groups of
protein serine/threonine kinase activity (GO:0004674), and
protein kinase activity (GO:0004672) are signiﬁcantly over-
represented (P < 1014). In the human proteome, there are
559 and 776 proteins annotated with the two GO terms respec-
tively, while there are 119 and 128 of them are among our data
set. Thus, it could be estimated that 1/5 serine/threonine ki-
nases could be sumoylated. This result is in accordance with
the hypothesis that crosstalk between sumoylation and phos-
phorylation may be fundamental and essential in signal trans-
duction [8].
Another interesting cellular process identiﬁed to be highly
relevant to sumoylation is the process of perception of sound
(GO:0007605) (P < 106). Thus, we propose that sumoylation
may play an important role in the perception of sound path-
ways, a novel ﬁnding that was never reported.
3.3. Signiﬁcantly represented protein domains in the data set
To provide further insight into the functional enrichment of
SUMO substrates, we also perform the statistical analysis to
obtain additional evidence of what types of protein domains
are more frequently encoded in them. Since sumoylation may
be mainly implicated in transcription regulation and signal
transduction by sumoylating transcription factors and protein
serine/threonine kinases, respectively, it could be anticipated
that some speciﬁc protein domains, such as DNA binding or
kinase, should be abundant in our data set.
The analysis on the InterPro annotations [32] satisfyingly
conﬁrms with the above results. The top 10 most enriched pro-
tein domains in SUMO substrates are listed (Table 4). It is not
surprising that the protein domains such as Serine/threonine
protein kinase, active site (IPR008271), Serine/threonine pro-
tein kinase (IPR002290), Zn-ﬁnger, C2H2 type (IPR007087),
and Zn-ﬁnger-like, PHD ﬁnger (IPR001965) are signiﬁcantly
abundant in the data set (P < 1015). Unexpectedly, we notice
that Pleckstrin-homology-related (IPR011036) and Pleckstrin-
like (IPR001849) are also in our top list. Pleckstrin homology
(PH) domains are small modular domains with 100 amino-
acid residues that occur once, or occasionally several times,
in a large variety of proteins involved in intracellular signaling
or as constituents of the cytoskeleton [36]. This observation
may propose that there are some speciﬁc protein domainsabundant in SUMO substrates to form links between sumoyla-
tion and signaling related pathways. Although most of the pro-
tein domains are focused on all kinds of DNA-binding
domain, Zn-ﬁnger, C2H2 type (IPR007087) domains can bind
both DNA and RNA. And we found that the domain of
RNA-binding region RNP-1 (RNA recognition motif)
(IPR000504) is signiﬁcant (P < 107). So our analysis also sup-
ports the hypothesis that sumoylation may play a role in RNA
metabolism [37].4. Discussion
In this paper, we provide a genome-scale analysis of sumoy-
lation-related biological processes and functions. The results
show that sumoylation may be strongly correlated with the
transcription regulation and signal transduction, which is con-
sistent with the experimental observations. Our analysis also
provides several other interesting hints, e.g., sumoylation
may be involved in the perception of sound, oﬀering insights
for further experimental manipulation. Taken together, our
data set establishes a good resource for potential SUMO sub-
strates with high speciﬁcity.5. Supplementary materials
Supplementary materials and the software SSP (SUMO Sub-
strates Prediction) implemented in Delphi are available from:
http://973-proteinweb.ustc.edu.cn/sumo/.
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